![Peter Griffith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Griffith
Financieel Directeur/CFO bij
AMGEN INC.
Vermogen: 17 M $ op 31-05-2026
Profiel
De heer Peter H. Griffith is Chief Financial Officer & Executive Vice President bij Amgen, Inc. De heer Griffith was voorheen werkzaam als President bij Sherwood Canyon Group LLC en als Managing Partner-Finance & Corporate Development bij Ernst & Young Global Ltd. Hij behaalde zijn bachelordiploma aan de USC Marshall School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AMGEN INC. 0,01% | 07-05-2026 | 50.150 ( 0,01% ) | 17 M $ | 31-05-2026 |
Actieve functies van Peter Griffith
| Bedrijven | Functie | Begin |
|---|---|---|
| AMGEN INC. | Financieel Directeur/CFO | 01-01-2020 |
| CHEMOCENTRYX, INC. | Financieel Directeur/CFO | - |
| FIVE PRIME THERAPEUTICS, INC. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Peter Griffith
| Bedrijven | Functie | Einde |
|---|---|---|
Sherwood Canyon Group LLC | President | 01-10-2019 |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01-09-1997 |
Ernst & Young Global Ltd.
 Ernst & Young Global Ltd. Other Consumer ServicesConsumer Services Provides tax, law, strategy, transaction and consulting services | Corporate Officer/Principal | - |
Opleiding van Peter Griffith
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
35
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
USC Marshall School of Business
 USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young Global Ltd.
Ernst & Young Global Ltd. Other Consumer ServicesConsumer Services Provides tax, law, strategy, transaction and consulting services | Consumer Services |
Sherwood Canyon Group LLC |
